<level type="section">
  <num>34-2202.06g</num>
  <heading>Wastewater study and testing.</heading>
  <level>
    <num>(a)</num>
    <text>By July 1, 2013, the Authority shall initiate a study that tests for the presence of endocrine disruptor compounds in wastewater effluent.</text>
  </level>
  <level>
    <num>(b)</num>
    <text>The Authority shall present the findings of the study to the Panel, the General Manager, the Mayor, and the Council within 30 days of the completion of the study.</text>
  </level>
  <level>
    <num>(c)</num>
    <text>The Authority shall be required to implement the provisions of this section upon a transfer by the Chief Financial Officer of the District from the unrestricted fund balance of the General Fund of the District of Columbia to the Authority of the funding necessary to implement the provisions of this section.</text>
  </level>
  <level>
    <num>(d)</num>
    <text>The District shall effectuate the transfer pursuant to subsection (c) of this section upon the inclusion of its fiscal effect in an approved budget and financial plan, as certified by the Chief Financial Officer to the Budget Director of the Council in a certification published by the Council in the District of Columbia Register.</text>
  </level>
  <level type="annotations">
    <level>
      <heading>History</heading>
      <text>(Apr. 18, 1996, D.C. Law 11-111, ยง 206g, as added Mar. 19, 2013, D.C. Law 19-240, ยง 2(b), 59 DCR 14790.)</text>
    </level>
    <level>
      <heading>Section References</heading>
      <text>This section is referenced in ยง 34-2202.06e.</text>
    </level>
    <level>
      <heading>Effect of Amendments</heading>
      <text>The 2013 amendment by D.C. Law 19-240 added this section.</text>
    </level>
    <level>
      <heading>Legislative History of Law 19-240</heading>
      <text>See note to ยง 34-2202.01.</text>
    </level>
  </level>
</level>
